(E)-N'-{4-[(3,4-dichloro-1-methyl-1H-pyrazol-5-yl)oxy]benzenesulfonyl}-N,N-dimethylmethanimidamide

Catalog No. :
ACLDDN937
CAS No. :
318284-22-9
Molecular Formula :
C13H14Cl2N4O3S
Molecular Weight :
377.25

IUPAC Name:(E)-N'-((4-((3,4-dichloro-1-methyl-1H-pyrazol-5-yl)oxy)phenyl)sulfonyl)-N,N-dimethylformimidamide

(E)-N'-{4-[(3,4-dichloro-1-methyl-1H-pyrazol-5-yl)oxy]benzenesulfonyl}-N,N-dimethylmethanimidamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$567.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-N'-{4-[(3,4-dichloro-1-methyl-1H-pyrazol-5-yl)oxy]benzenesulfonyl}-N,N-dimethylmethanimidamide
IUPAC Name(E)-N'-((4-((3,4-dichloro-1-methyl-1H-pyrazol-5-yl)oxy)phenyl)sulfonyl)-N,N-dimethylformimidamide
MDL No.MFCD00127492
Molecular FormulaC13H14Cl2N4O3S
Molecular Weight377.25
SMILESCN(C)/C=N/S(=O)(C1=CC=C(OC2=C(Cl)C(Cl)=NN2C)C=C1)=O
InChI KeyXNCXBOMMIVVUAF-LZYBPNLTSA-N
Synonym4-[(3,4-DICHLORO-1-METHYL-1H-PYRAZOL-5-YL)OXY]-N-[(DIMETHYLAMINO)METHYLENE]BENZENESULFONAMIDE;N'-[4-(4,5-dichloro-2-methylpyrazol-3-yl)oxyphenyl]sulfonyl-N,N-dimethylmethanimidamide;Benzenesulfonamide, 4-[(3,4-dichloro-1-methyl-1H-pyrazol-5-yl)oxy]-N-[(dimethylamino)methylene]-
CAS No.318284-22-9

Synthetic Route by SureRoute

1. ACLDDN937 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLDDN937 route product structure diagram
    ACLDDN937318284-22-9
Inquiry

2. ACLDDN937 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLDDN937 route product structure diagram
    ACLDDN937318284-22-9
Inquiry

Comments (0)